Your next first.
When was the last time you did something…
for the first time?
Longevity isn't about postponing your last day.
It's about creating more first days.
The big idea
Don't measure your future in years.
Measure it in firsts.
The real promise of longevity isn't simply living longer. It's extending the years when we can still create, contribute, experience, grow, discover, love, dream — and do something we've never done before.
-
Another
adventure -
Another
idea -
Another
place -
Another person
you can help -
Another
challenge -
Another
first
Why longevity matters
Living longer is only half the story.
What would you do with more years of strength, clarity and possibility? Longevity science asks how we might better understand the biology of aging and extend healthspan — the period of life spent in good health.
Our focus is the years in which people remain capable, engaged and independent. We do not promise a specific number of additional years to anyone. The honest goal is a longer stretch of life in which another first is still possible.
- Lifespan
- The total number of years lived.
- Healthspan
- The years lived in good health — capable, engaged and independent.
The Klotho story
Meet Klotho.
Klotho is a longevity-associated protein produced mainly in the kidneys and also expressed in the brain — named for the Greek goddess who spins the thread of life. It has roles in mineral metabolism and has been studied in connection with cellular stress, cardiovascular biology, cognition and aging. In plain terms: it helps regulate mineral balance, has been studied for its role in protecting cells from stress, and is an active research subject in brain and heart health. Klotho levels and expression decline with age, making the pathway an active area of longevity research.
The Klotho pathway
Stages 1–2: Established biology Stage 3: Emerging evidence Stage 4: Investigational concept
The processes in stage three are associated with aging and studied alongside Klotho in the research literature; they are not established as demonstrated consequences of Klotho decline in humans. Stage four is an investigational strategy, not a demonstrated result.
Each step above is sourced in the Science & Evidence section. Associations reported in research are not the same as proven cause and effect in humans.
The Klothosome concept — investigational
The frontier is delivery.
Klotho is a large, fragile protein, and getting it where it needs to go is the hard part. Extracellular vesicles are tiny lipid-bound packages cells naturally use to ship proteins and genetic material to one another — a delivery system the body already recognises. Load Klotho into an extracellular vesicle and you have what the field has begun calling a Klothosome. The Klothosome concept explores whether an engineered extracellular-vesicle approach could serve as a potential delivery strategy for Klotho.
-
Klotho
A longevity-associated biological signal.
-
Delivery challenge
How might Klotho be delivered effectively to relevant tissues?
-
Extracellular vesicles
Natural biological carriers being explored for therapeutic delivery.
-
Klothosome
Our investigational concept connecting Klotho biology with advanced delivery science.
The FIRST. campaign
When was the last time you did something… for the first time?
Longevity isn't about postponing your last day. It's about creating more first days.
At Longevity Gladiators, we believe the real promise of longevity isn't simply living longer. It's extending the years when we can still create, contribute, experience, grow, discover, love, dream, and do something for the first time.
Another adventure. Another idea. Another company. Another place you've never seen. Another person you can help. Another challenge you never thought you'd attempt. Another moment when you can say: I've never done this before.
Don't measure your future in years.
Measure it in firsts.
What's your next first?
Type it, and we'll set it in the FIRST. card below. Typed privately in your browser — nothing is saved, stored, collected or sent anywhere.
0/90
Science & evidence
Every claim sourced.
We don't hype longevity — we make it understandable. Every statement on this site is labelled by how strong the evidence behind it is, and by what was actually studied: humans, animals or cells.
Supported by multiple independent sources.
Promising but incomplete. Often observational or early-stage.
A hypothesis or development direction — not a proven clinical outcome.
| Claim | Study type | Model | Evidence label | Source |
|---|---|---|---|---|
| Disrupting the klotho gene produces a syndrome resembling accelerated aging. | Primary research | Animal (mouse) | Established | Kuro-o M, et al. Nature 1997;390:45–51. doi:10.1038/36285 |
| Overexpression of Klotho extended lifespan in mice. | Primary research | Animal (mouse) | Established | Kurosu H, et al. Science 2005;309:1829–33. doi:10.1126/science.1112766 |
| Soluble α-Klotho in blood declines with age in healthy people. | Assay development / cohort | Human | Established | Yamazaki Y, et al. Biochem Biophys Res Commun 2010;398:513–8. doi:10.1016/j.bbrc.2010.06.110 |
| Klotho has roles in mineral metabolism and is a co-receptor for FGF23. | Review | Human / animal | Established | Kuro-o M. Nat Rev Nephrol 2019;15:27–44. doi:10.1038/s41581-018-0078-3 |
| A functional human klotho variant (KL-VS) has been associated with longevity. | Genetic association | Human | Emerging | Arking DE, et al. PNAS 2002;99:856–61. doi:10.1073/pnas.022484299 |
| Lower plasma klotho has been associated with mortality risk in older adults. | Observational cohort | Human | Emerging | Semba RD, et al. J Gerontol A Biol Sci Med Sci 2011;66:794–800. doi:10.1093/gerona/glr058 |
| Klotho has been studied in connection with cognition. | Primary research + cohort | Animal + human | Emerging | Dubal DB, et al. Cell Reports 2014;7:1065–76. doi:10.1016/j.celrep.2014.03.076 |
| Klotho administration was reported to enhance cognition in aged nonhuman primates. | Primary research | Animal (nonhuman primate) | Emerging | Castner SA, et al. Nature Aging 2023;3:931–7. doi:10.1038/s43587-023-00441-x |
| Extracellular vesicles are lipid-bound particles that carry biological cargo between cells. | Review | Human / animal / in vitro | Established | Kalluri R, LeBleu VS. Science 2020;367:eaau6977. doi:10.1126/science.aau6977 |
| Extracellular vesicles are being explored as therapeutic delivery vehicles. | Review | Preclinical / in vitro | Emerging | Wiklander OPB, et al. Sci Transl Med 2019;11:eaav8521. doi:10.1126/scitranslmed.aav8521 |
| Klothosome — an engineered extracellular-vesicle approach to Klotho delivery. | Concept | No human data | Investigational | LG26 concept. Hypothesis and development direction only; no clinical evidence exists. |
Reference library compiled by LG26 from published, publicly available scientific literature. Citations should be re-verified against the primary sources before any public or commercial use of this material.
How LG26 wins with the rules
Show the sequence, not just the artifact.
The strongest story is a visible sequence documented in the daily reports:
Innovation Marketing Execution Learning Refinement Impact
-
Upload 1
The idea
Show the problem, insight, brand concept, hypothesis, and what LG26 intends to test.
-
Upload 2
The market test
Show what was created, how the message was tested without prohibited data collection, and what the response was.
-
Upload 3
The impact story
Show the refined artifact, the lessons learned, and evidence of value created during the event.
72-hour execution plan
-
Hours 0–24 Lock the science
Source and verify every claim. Build the one-page fact base with citations. Define the single core message.
-
Hours 24–48 Build the artifact
Visual explainer plus the ninety-second narrative. Test it on someone with zero background. If they can't repeat it back, rewrite it.
-
Hours 48–72 Refine and deliver
Stress-test for accuracy. Submit the finished asset plus the case for why this matters commercially.
Our standard Every claim sourced. We don't hype longevity, we make it understandable.
About
Longevity Gladiators | LG26
Live Better. Live Stronger. Live Longer.
LG26 formed around a single conviction: the biggest untapped market in health isn't treating disease, it's extending healthy human lifespan. We assembled, named ourselves, and locked our identity in under a day.
Longevity science is moving faster than public understanding. Breakthroughs sit trapped in journals while ordinary people have no idea what's actually possible for their own healthspan. The gap isn't discovery. It's translation — turning complex biology into ideas people can understand, remember and act on responsibly.
So we are building the clearest, most compelling explanation of Klotho and Klothosome science that exists. Not a paper. Not a pitch. A translation a non-scientist understands in ninety seconds and remembers for a year.
Mission
To make emerging longevity science understandable, compelling and human — while maintaining scientific discipline about what is established, what is promising and what remains investigational.
Project
Klothosome Longevity Initiative — an educational and investigational concept focused on Klotho biology and potential advanced delivery approaches.